MYP_014866
Ecallantide
Immunology
▸
Immune modulation
▸
Immunomodulatory activity
Standard
60 amino acids
C305H448N88O91S8
Standard
EAMHSFCAFKADDGPCRAAHPRWFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD
7059.88 Da
5.61
-2.03
-2.41
-0.0338
-0.71
0.62
-0.15
60.11
27.83
0.1500
6990.00
7365.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
2912.95
-29.75
106.0
99.0
232.0
492.0
14.0
64.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0276597
VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; Saccharomyces cerevisiae [Fungus]
Enzyme
9606;4932
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Disulfide-bonded therapeutic scaffold described in source text
Lipidation
Bio-Activity Profile
Immunomodulatory
Coagulation factor replacement
Following subcutaneous administration of 30 mg ecallantide, the mean elimination half-life was 2.0 ± 0.5 hours [FDA Label].